M A Rudek Selected Research

MTOR Inhibitors

8/2010

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Rudek Research Topics

Disease

5	Neoplasms (Cancer) 07/2014 - 01/2001
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2009
1	Hypertension (High Blood Pressure) 07/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2014
1	Prostatic Neoplasms (Prostate Cancer) 12/2013
1	Hyponatremia 01/2012
1	Neutropenia 01/2012
1	Leukemia 08/2010
1	Anemia 05/2001
1	Sideroblastic Anemia 05/2001
1	Fever (Fevers) 04/2001
1	Exanthema (Rash) 04/2001

Drug/Important Bio-Agent (IBA)

3	tetracycline CMT-3IBA 05/2001 - 01/2001
2	Sorafenib (BAY 43-9006)FDA Link 07/2014 - 08/2010
2	Gemcitabine FDA Link 08/2010 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 08/2010 - 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2014
1	Antineoplastic Agents (Antineoplastics)IBA 04/2014
1	Disulfiram (Antabuse)FDA Link 12/2013
1	entinostat (MS 275)IBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 08/2010
1	MTOR InhibitorsIBA 08/2010
1	TOR Serine-Threonine KinasesIBA 08/2010
1	temsirolimus FDA Link 08/2010
1	ON 01910IBA 01/2009
1	Tetracycline (Achromycin)FDA LinkGeneric 05/2001
1	Antinuclear AntibodiesIBA 04/2001
1	Matrix Metalloproteinases (MMPs)IBA 01/2001
1	Matrix Metalloproteinase InhibitorsIBA 01/2001

Therapy/Procedure

1	Aftercare (After-Treatment) 07/2014
1	Drug Therapy (Chemotherapy) 04/2014
1	Therapeutics 04/2001